tradingkey.logo
tradingkey.logo
Search

Ovid Therapeutics Enters Agreement With Immedica Pharma AB For Sale Of Future Ganaxolone Royalties

ReutersJun 25, 2025 12:22 PM
facebooktwitterlinkedin

- Ovid Therapeutics Inc OVID.O:

  • OVID THERAPEUTICS ENTERS AGREEMENT WITH IMMEDICA PHARMA AB FOR SALE OF FUTURE GANAXOLONE ROYALTIES

  • OVID THERAPEUTICS INC - IMMEDICA TO PAY $7 MILLION FOR GANAXOLONE ROYALTY RIGHTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI